-
1
-
-
0030737627
-
Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management
-
Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood. 1997; 90: 999-1008.
-
(1997)
Blood
, vol.90
, pp. 999-1008
-
-
Boutati, E.I.1
Anaissie, E.J.2
-
2
-
-
35448960891
-
Fusarium infections in immunocompromised patients
-
Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007; 20: 695-704.
-
(2007)
Clin Microbiol Rev
, vol.20
, pp. 695-704
-
-
Nucci, M.1
Anaissie, E.2
-
3
-
-
46249130819
-
Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy
-
Tortorano AM, Prigitano A, Dho G, Esposto MC, Gianni C, Grancini A, Ossi C, Viviani MA. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother. 2008; 52: 2683-5.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 2683-2685
-
-
Tortorano, A.M.1
Prigitano, A.2
Dho, G.3
Esposto, M.C.4
Gianni, C.5
Grancini, A.6
Ossi, C.7
Viviani, M.A.8
-
4
-
-
77950513662
-
Molecular phylogenetic diversity of dermatologic and other human pathogenic fusarial isolates from hospitals in northern and central Italy
-
Migheli Q, Balmas V, Harak H, Sanna S, Scherm B, Aoki T, O'Donnell K. Molecular phylogenetic diversity of dermatologic and other human pathogenic fusarial isolates from hospitals in northern and central Italy. J Clin Microbiol. 2010; 48: 1076-84.
-
(2010)
J Clin Microbiol
, vol.48
, pp. 1076-1084
-
-
Migheli, Q.1
Balmas, V.2
Harak, H.3
Sanna, S.4
Scherm, B.5
Aoki, T.6
O'Donnell, K.7
-
5
-
-
0038556830
-
Voriconazole treatment for less-common, emerging, or refractory fungal infections
-
Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, De la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis. 2003; 36: 1122-31.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 1122-1131
-
-
Perfect, J.R.1
Marr, K.A.2
Walsh, T.J.3
Greenberg, R.N.4
Dupont, B.5
de la Torre-Cisneros, J.6
Just-Nübling, G.7
Schlamm, H.T.8
Lutsar, I.9
Espinel-Ingroff, A.10
Johnson, E.11
-
6
-
-
42549092364
-
Posaconazole (Noxafil): a new triazole antifungal agent
-
Greer ND. Posaconazole (Noxafil): a new triazole antifungal agent. Proc Baiyl Univ Med Cent. 2007; 20: 188-96.
-
(2007)
Proc Baiyl Univ Med Cent
, vol.20
, pp. 188-196
-
-
Greer, N.D.1
-
7
-
-
65649106220
-
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum
-
Ruíz-Cendoya M, Mariné M, Rodríguez MM, Guarro J. Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum. Antimicrob Agents Chemother. 2009; 53: 1705-8.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 1705-1708
-
-
Ruíz-Cendoya, M.1
Mariné, M.2
Rodríguez, M.M.3
Guarro, J.4
-
8
-
-
49649098015
-
Combined therapy in treatment of murine infection by Fusarium solani
-
Ruíz-Cendoya M, Mariné M, Guarro J. Combined therapy in treatment of murine infection by Fusarium solani. J Antimicrob Chemother. 2008; 62: 543-6.
-
(2008)
J Antimicrob Chemother
, vol.62
, pp. 543-546
-
-
Ruíz-Cendoya, M.1
Mariné, M.2
Guarro, J.3
-
9
-
-
34247608790
-
Treating disseminated fusariosis: Amphotericin B, voriconazole or both?
-
Ho DY, Lee JD, Rosso F, Montoya JG. Treating disseminated fusariosis: Amphotericin B, voriconazole or both? Mycoses. 2007; 50: 227-31.
-
(2007)
Mycoses
, vol.50
, pp. 227-231
-
-
Ho, D.Y.1
Lee, J.D.2
Rosso, F.3
Montoya, J.G.4
-
10
-
-
0037357159
-
Successful treatment of disseminated fusariosis
-
Rodriguez CA, Luján-Zilbermann J, Woodard P, Andreansky M, Adderson EE. Successful treatment of disseminated fusariosis. Bone Marrow Transplant. 2003; 31: 411-2.
-
(2003)
Bone Marrow Transplant
, vol.31
, pp. 411-412
-
-
Rodriguez, C.A.1
Luján-Zilbermann, J.2
Woodard, P.3
Andreansky, M.4
Adderson, E.E.5
-
12
-
-
0002515716
-
Antimicrobial combinations
-
3rd edn., V. Lorian (Ed.), Baltimore: The Williams & Wilkins Co
-
Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V, editor. Antibiotics in laboratory medicine. 3rd ed. Baltimore: The Williams & Wilkins Co; 1991. p. 432-92.
-
(1991)
Antibiotics in Laboratory Medicine
, pp. 432-492
-
-
Eliopoulos, G.M.1
Moellering, R.C.2
-
13
-
-
0031665183
-
Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: Role of immune suppression
-
Graybill JR, Bocanegra R, Najvar LK, Loebenberg D, Luther MF. Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: Role of immune suppression. Antimicrob Agents Chemother. 1998; 42: 2467-73.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 2467-2473
-
-
Graybill, J.R.1
Bocanegra, R.2
Najvar, L.K.3
Loebenberg, D.4
Luther, M.F.5
-
14
-
-
28844507822
-
Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis
-
Clemons KV, Espiritu M, Parmar R, Stevens DA. Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrob Agents Chemother. 2005; 49: 4867-75.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 4867-4875
-
-
Clemons, K.V.1
Espiritu, M.2
Parmar, R.3
Stevens, D.A.4
-
15
-
-
33646445731
-
Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions
-
Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, Kontoyiannis DP. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006; 42: 1398-403.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 1398-1403
-
-
Raad, I.I.1
Hachem, R.Y.2
Herbrecht, R.3
Graybill, J.R.4
Hare, R.5
Corcoran, G.6
Kontoyiannis, D.P.7
-
16
-
-
58849116012
-
Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation
-
Tezcan G, Ozhak-Baysan B, Alastruey-Izquierdo A, Ogunc D, Ongut G, Yildiran ST, Hazar V, Cuenca-Estrella M, Rodriguez-Tudela JL. Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. J Clin Microbiol. 2009; 47: 278-81.
-
(2009)
J Clin Microbiol
, vol.47
, pp. 278-281
-
-
Tezcan, G.1
Ozhak-Baysan, B.2
Alastruey-Izquierdo, A.3
Ogunc, D.4
Ongut, G.5
Yildiran, S.T.6
Hazar, V.7
Cuenca-Estrella, M.8
Rodriguez-Tudela, J.L.9
|